Oslo Balloon Angioplasty Versus Conservative Treatment

Status Completed

Clinical Trial Summary

Background: Percutaneous transluminal angioplasty (PTA) has been popularized as a simple, effective and cheap treatment achieving 50-70% symptomatic patency rates in patients with peripheral occlusive disease.. However, the fact remains that the indication for performing PTA are still more based on opinions than on scientific data.

The purpose of the trial was to randomize patients primarily referred for intermittent claudication into two groups: One group was offered conservative treatment; the other group was offered conservative treatment combined with PTA.

Primary outcome: The patient quality of life. Secondary outcome:Pain-free walking distance; pain-score; death; amputation; changes in relevant biomarkers

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00222196
Study type	Interventional
Source	Oslo University Hospital
Contact
Status	Completed
Phase	N/A
Start date	November 2000
Completion date	December 2004

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05335525` - Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)
Active, not recruiting	`NCT01903044` - Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating	Phase 1/Phase 2
Completed	`NCT02228564` - BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease	N/A
Completed	`NCT02271529` - Zilver PTX Delivery System	N/A
Recruiting	`NCT02054871` - RCT to Evaluate the Renal Protective Effects of Remote Ischaemic Preconditioning in Peripheral Angioplasty	N/A
Completed	`NCT00822172` - Evaluation of Cilostazol in Combination With L-Carnitine	Phase 4
Completed	`NCT00574782` - Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)	N/A
Completed	`NCT00029991` - Extract of Ginkgo Biloba (EGB 761) and Vascular Function	Phase 1/Phase 2
Completed	`NCT01355406` - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System	N/A
Recruiting	`NCT05804097` - Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?	Phase 4
Recruiting	`NCT03638115` - The VaSecure BTK Study	N/A
Active, not recruiting	`NCT03241459` - Safety and Efficacy of the SurVeil™ Drug-Coated Balloon	N/A
Active, not recruiting	`NCT01661231` - Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe	N/A
Completed	`NCT01722877` - JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions	N/A
Completed	`NCT01444378` - Absolute Pro® MOMENTUM™	N/A
Completed	`NCT00753337` - The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study	N/A
Completed	`NCT00593385` - Atrium iCAST Iliac Stent Pivotal Study	N/A
Completed	`NCT00538226` - Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg	Phase 1
Recruiting	`NCT00385385` - RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease	Phase 2
Completed	`NCT00392509` - ALD-301 for Critical Limb Ischemia, Randomized Trial	Phase 1/Phase 2